Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules

Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules

Background Effective means for early diagnosis are imperative to reduce death rate of non-small cell lung cancer (NSCLC) patients. We aimed to find out high-performance serologic markers to distinguish early-stage NSCLC patients from benign pulmonary nodule patients and healthy controls (HC). Cystat...

Full description

Bibliographic Details
Main Authors: Yanzhen Lai MM, Yu Wang MM, Yaxian Wu MM, Meng Wu MM, Shan Xing MM, Ying Xie MD, Shulin Chen MM, Xiaohui Li MM, Ao Zhang MD, Yi He MD, Huilan Li MM, Shuqin Dai MM, Junye Wang MM, Shudai Lin MM, Yunmeng Bai MM, Hongli Du PhD, Wanli Liu MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2022-05-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748221104661

Internet

https://doi.org/10.1177/10732748221104661

Similar Items